-transparent.png){kind=logo}
BACKGROUND The aim was to investigate the effect of tiapride (100 mg three times a day for at least one month) on outcome following detoxification. METHODS The setting was a tertiary referral centre. The study design was randomised, double-blind, and placebo-controlled. One hundred routinely admitted alcohol-dependent patients were entered, and 54 completed the trial. Outcome was assessed by considering drinking status at three months and six months follow-up, and by comparing psychological status at intake and follow-up using the Crown-Crisp Experiential index, the Litman Self-esteem scale and a Satisfaction with Life Situations scale. We also compared performance over the six months before admission with the three and six months of follow-up on measures of health, social and drinking variables. RESULTS Tiapride proved better (usually at statistically highly significant levels) than placebo at promoting: abstinence, self-esteem, and satisfaction with life situations; and at reducing: alcohol consumption, use of health service resources, and levels of neuroticism. CONCLUSIONS Tiapride merits serious consideration in the longer-term treatment of alcoholic patients.
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
April 1979,
The American journal of psychiatry,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
January 2001,
Alcohol and alcoholism (Oxford, Oxfordshire),
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
July 1979,
La Nouvelle presse medicale,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
January 1993,
Journal of studies on alcohol,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
November 2003,
Archives of women's mental health,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
April 1984,
Journal of clinical psychopharmacology,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
January 1996,
Journal of substance abuse,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
April 1998,
Archives of general psychiatry,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
January 2006,
Neuropsychobiology,
G K Shaw, and
S Waller, and
S K Majumdar, and
J L Alberts, and
C J Latham, and
G Dunn
August 2012,
Journal of clinical psychopharmacology,
